Moutih Rafei

Dr. Moutih Rafei is a renowned biomedical scientist, academic leader, and biotechnology innovator whose trailblazing research in cellular immunology, stem cell engineering, and regenerative medicine has earned international acclaim. Serving as a Principal Investigator, Professor, and Chief Scientific Officer, Dr. Rafei has dedicated his career to demystifying the complex interactions between the immune system and malignant or degenerative diseases.

At the core of Dr. Rafei's scientific contributions is his groundbreaking work with mesenchymal stem cells (MSCs) and their secretome. His laboratory has pioneered novel bio-engineering techniques to reprogram stem cells, generating targeted cell-based therapeutics that can selectively suppress autoimmune inflammatory cascades or activate antitumor immunity without the systemic toxicity commonly associated with traditional chemotherapy.

Bridging the notorious "valley of death" between laboratory bench research and clinical bedside commercialization has been Dr. Rafei's signature achievement. By forging strategic alliances between academic medical centers and venture-backed biopharmaceutical entities, he has successfully transitioned multiple candidate molecules through rigorous pre-clinical pipelines toward active human clinical trials.

A prolific author with dozens of high-impact publications in premier scientific journals, Dr. Rafei is equally recognized for his dedication to cultivating the next generation of biomedical scientists. His lab serves as an international incubator for young researchers, emphasizing interdisciplinary collaboration between molecular biology, data science, and clinical oncology.

As healthcare enters the era of personalized medicine, Dr. Rafei continues to lead the vanguard of precision cellular immunotherapy, advancing treatments that offer renewed hope to patients facing refractory autoimmune conditions and previously intractable cancers.